TrialEndocrinology, diabetes & metabolism2025

The Comparison of the Effect of Adding Empagliflozin to the Medication Regimen on Peripheral Neuropathy in Patients With Type II Diabetes: A Double Blind Randomised Clinical Trial.

Mohammadreza Vafaeinasab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.